News / Health

Human Ebola Vaccine Trials to Begin

Ebola Vaccine Trials To Begin Next Weeki
X
August 29, 2014 2:18 AM
The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.

Watch related video report from VOA's Zlatica Hoke.

Joe DeCapua

U.S. health officials announced Thursday the launch of the first human testing of a vaccine to prevent Ebola. The vaccine candidate was co-developed by the National Institute of Allergy and Infectious Diseases - and the pharmaceutical company GSK (GlaxoSmithKline).

Dr. Anthony Fauci says vaccine research has accelerated since the Ebola epidemic was first reported in West Africa last March.

"We are announcing the opening of a small human safety study of an investigational Ebola vaccine candidate that will be tested here at the NIH," he said. "This is the first of several Phase One clinical trials of Ebola vaccine candidates that we are set to launch."

Fauci is the head of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. He describes the West Africa Ebola outbreak as a “public health emergency that demands an all hands on deck response.”

"We have accelerated the time line for testing experimental Ebola vaccines that we have been developing for several years," he said. "And after an expedited review of the candidate product and clinical trial design by the United States Food and Drug Administration we have the green light to begin."

He says the trials will be based on three earlier versions of Ebola vaccine candidates. Those trials led to the vaccine that is now being studied. Next week, the first three volunteers will be enrolled in a study known as VRC207.

"The trial aims to enroll 20 healthy adults - ages 18 to 50 years - at the NIH Clinical Research Center here in Bethesda, Maryland," he said. "The study will evaluate the experimental vaccine’s safety and whether it generates an immune response in healthy adults that - based on our animal studies - could predict effectiveness in preventing the acquisition of Ebola infection."

Fauci says earlier studies of the experimental vaccine performed extremely well in protecting primates from Ebola infection.  The current vaccine candidate uses a chimpanzee cold virus. The virus carries a gene related to the surface protein of the Zaire and Sudan strains of the Ebola virus. The Zaire strain is blamed for the West Africa epidemic.

"It is important to know that the Ebola gene contained in the investigational vaccine cannot cause a vaccinated individual to become infected with Ebola," he said. "The volunteers in the VRC207 trial will be divided into two groups to test first a lower and then a higher does of the vaccine.

The vaccine will be administered through an injection in the arm. The trial is scheduled to last 48 weeks, but initial findings could be available by the end of this year.  

In October, a second trial will begin in the U.S., Britain, Mali and The Gambia to test a vaccine candidate that contains genetic material from only one of the Ebola strains.

Fauci says despite the vaccine research, precaution and prevention are the best defense right now against the disease.

You May Like

Turkey's Controversial Reform Bill Giving Investors Jitters

Homeland security reform bill will give police new powers in search, seizure, detention and arrests, while restricting the rights of suspects, their attorneys More

Audio Slideshow In Kenyan Prison, Good Grades Are Path to Freedom

Some inmates who get high marks could see their sentences commuted to non-custodial status More

'Rumble in the Jungle' Turns 40

'The Champ' knocked Foreman out to regain crown he had lost 7 years earlier when US government accused him of draft-dodging and boxing officials revoked his license More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Victorious Secularists Face Challenge to Form Government in Tunisiai
X
Henry Ridgwell
October 30, 2014 11:39 PM
Official results from Tunisia show the Islamist Ennahda party has failed to win the second free election since the so-called "Arab Spring" uprising in 2011. Ennahda, which handed power to a government of technocrats pending the elections, lost out to the secular party Nidaa Tounes. Henry Ridgwell reports from London that the relatively peaceful poll offers some hope in a volatile region.
Video

Video Victorious Secularists Face Challenge to Form Government in Tunisia

Official results from Tunisia show the Islamist Ennahda party has failed to win the second free election since the so-called "Arab Spring" uprising in 2011. Ennahda, which handed power to a government of technocrats pending the elections, lost out to the secular party Nidaa Tounes. Henry Ridgwell reports from London that the relatively peaceful poll offers some hope in a volatile region.
Video

Video Africa Tells its Story Through Fashion

In Africa, Fashion Week is a riot of colors, shapes, patterns and fabrics - against the backdrop of its ongoing struggle between nature and its fast-growing urban edge. How do these ideas translate into needle and thread? VOA’s Anita Powell visited this year’s Mercedes Benz Fashion Week Africa in Johannesburg to find out.
Video

Video Smugglers Offer Cheap Passage From Turkey to Syria

Smugglers in Turkey offer a relatively cheap passage across the border into Syria. Ankara has stepped up efforts to stem the flow of foreign fighters who want to join Islamic State militants fighting for control of the Syrian border city of Kobani. But porous borders and border guards who can be bribed make illegal border crossings quite easy. Zlatica Hoke has more.
Video

Video China Political Meeting Seeks to Improve Rule of Law

China’s communist leaders will host a top level political meeting this week, called the Fourth Plenum, and for the first time in the party’s history, rule of law will be a key item on the agenda. Analysts and Chinese media reports say the meetings could see the approval of long-awaited measures aimed at giving courts more independence and include steps to enhance an already aggressive and high-reaching anti-corruption drive. VOA’s Bill Ide has more from Beijing.
Video

Video After Decades of Pressure, Luxembourg Drops Bank Secrecy Rules

European Union finance ministers have reached a breakthrough agreement that will make it more difficult for tax cheats to hide their money. The new legislation, which had been blocked for years by countries with a reputation as tax havens, was approved last week after Luxembourg and Austria agreed to lift their vetoes. But as Mil Arcega reports, it doesn’t mean tax cheats have run out of places to keep their money hidden.
Video

Video Kobani Refugees Welcome, Turkey Criticizes, US Airdrop

Residents of Kobani in northern Syria have welcomed the airdrop of weapons, ammunition and medicine to Kurdish militia who are resisting the seizure of their city by Islamic State militants. The Turkish government, however, has criticized the operation. VOA’s Scott Bobb reports from southeastern Turkey, across the border from Kobani.

All About America

AppleAndroid